photo

Improve Research, Brand & Provider Insights

Attest Open Payments™ represents a census of all direct and indirect financial activities, interests and their relationship between industry and a critical portion of all U.S. healthcare providers.  This census can be used to comprehensively understand the the compensation of all healthcare providers pertaining to research and brand related compensation, identify influential healthcare providers (e.g., key opinion leaders, principal investigators, clinical sites), and to objectively and precisely benchmark brand spend and budget.

Improve Insight

Understand Competitive Landscape

Attest™ identifies and characterizes the relationships and histories between competitive manufacturers and their key opinion leaders, principal investigators, physicians and teaching hospitals.  These relationships and histories are further analyzed to discern patterns and trends in the utilization of physicians and teaching hospitals in the context of clinical study sites and brands.  In the end, Attest™ provides a singular view of the competitive landscape based on selectable areas competitive insight.

Identify Influential Healthcare Providers

Attest™ identifies and ranks key opinion leaders, principal investigators, physicians and teaching hospitals based on their utilization and relative influence.  Attest™ stratifying further these healthcare providers by therapeutic area, indication, medical specialty, phase of development, life-cycle of brand, geospatially, and specific clinical research studies and product brands.  Once the influential healthcare providers are identified, Attest™ provides a powerful basis for selecting future key opinion leaders, principal investigators and clinical research sites.

Benchmark Brands & Budget

Attest™ objectively and precisely benchmarks brand spend based on a variety of selectable dimensions including therapeutic areas, indications, medical specialties, phase of development, life-cycle of brand, geospatially, and specific clinical research studies and product brands.  Then these benchmarks can be used to develop competitively and empirically supported financial plans and budget for specific brands, programs or therapeutic areas.

Frequently Asked Questions

  • Who are my competitors working with and for what reason?
  • Who are the most influential key opinion leaders we should be working with?
  • Who are the highest performing principal investigators we should be working with?
  • What physicians may have a conflict of interest?
  • How can I benchmark by physician spend budget?

Blog Articles

Caveat User, Caveat Emptor - Issues from the Soft Under Belly of The CMS Data Sets
Read More >

Detecting the "Sham" in Speaker Programs
Read More >

“Open Payments – A New Source of Clinical Site Intelligence”
Read More >

Workshop Speaker, "Demonstrating Compliance to the Department of Justice"
Read More >

Coauthor, “Are Phase 3 Clinical Trials Really Becoming More Complex?”
Read More >

View All Company News >